Search Videos and More
News
Dana-Farber Research News 10.15.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 16 - September 30.
Course
Dana-Farber Center for BRCA & Related Genes Scientific Symposium
Explore the latest advances in hereditary cancer research and care at the Dana-Farber Center for BRCA and Related Genes Scientific Symposium, designed for clinicians and researchers to deepen knowledge of detection, treatment, and ethical issues in BRCA-associated cancers across multiple tumor types.
News
Breast, Lung, and Bladder Cancer Phase 3 Trials led by Dana-Farber Presented at ESMO Congress 2025
Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany.
News
Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 19th Year in a Row
U.S. News & World Report has recognized Dana-Farber/Boston Children's Cancer and Blood Disorders Center as the #3 pediatric cancer program in the nation in its 2025-2026 Best Children's Hospitals report.
Document
Expert Review: Communicating Risk and Uncertainty in the Context of Genomic Testing
The Breast Oncology Center developed this reference for providers based on a presentation by Professor Dame Lesley Fallowfield given on October 23, 2024.
Document
Tip Sheet: QTc Monitoring in Breast Cancer Patients
The Breast Oncology Center developed this reference for QTc monitoring for breast cancer patients based on a presentation given on October 16, 2024, by Anju Nohria, MD, MSc, director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center
Document
Tip Sheet: Adrenal Insufficiency in Breast Cancer Patients
The Breast Oncology Center developed this reference for providers treating breast cancer patients with adrenal insufficiency in July 2025.
News
Dana-Farber Research News 10.01.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 1 through September 15.
News
Cracking the Code
It was 2014 and Filbin was a hematology/oncology fellow specializing in pediatric brain cancer. Her mentor, David Williams, MD, now associate chair of Pediatric Oncology at Dana-Farber, wanted her to go to a lab at the Massachusetts Institute of Technology (MIT) for the research portion of her fellowship.
News
New Diagnostic Tool Developed at Dana-Farber Revolutionizes Acute Leukemia Diagnosis
Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified and treated.
Document
AACR Pediatric Special Conference in Cancer Research
September 25 - 28, 2025, Boston, MA
News
Dana-Farber Research News 09.15.2025
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from August 16 - August 31.